Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2

Molecular Endocrinology

Volumn 21, Issue 3, 2007, Pages 613-624

  Nair, Sujit S ^a   Guo, Zhiyong ^d   Mueller, Judith M ^c   Koochekpour, Shahriar ^b   Qiu, Yun ^d   Tekmal, Rajeshwar Rao ^a   Schüle, Roland ^c   Kung, Hsing Jien ^e   Kumar, Rakesh ^f   Vadlamudi, Ratna K ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; FOUR AND A HALF LIM ONLY PROTEIN 2; LIM PROTEIN; PROLINE GLUTAMIC ACID AND LEUCINE RICH PROTEIN 1; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MUSCLE PROTEINS; NIH 3T3 CELLS; PROSTATIC NEOPLASMS; PROTEIN INTERACTION MAPPING; RECEPTORS, ANDROGEN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 33847194532     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0269     Document Type: Article

References (43)

1. Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, Sahin A, Kumar R 2001 Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor α. J Biol Chem 276:38272-38279
2. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
3. Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK 2004 Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. Cancer Res 64:6416-6423
4. Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, Sahin AA, Kumar R 2005 Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 65:7724-7732
5. Vadlamudi RK, Balasenthil S, Broaddus RR, Gustafsson JA, Kumar R 2004 Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J Clin Endocrinol Metab 89:6130-6138
6. Rajhans R, Vadlamudi RK 2006 Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered NR coregulator PELP1/MNAR. J Clin Exp Metastasis 23:1-7
7. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
8. Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobisch A 2004 Expression and function of androgen receptor coactivators in prostate cancer. J Steroid Biochem Mol Biol 92:265-271
9. Wang L, Hsu CL, Chang C 2005 Androgen receptor corepressors: an overview. Prostate 63:117-130
10. Shang Y, Myers M, Brown M 2002 Formation of the androgen receptor transcription complex. Mol Cell 9:601-610
11. Heinlein CA, Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
12. Chang CY, McDonnell DP 2005 Androgen receptor-cofactor interactions as targets for new drug discovery. Trends Pharmacol Sci 26:225-228
13. Morgan ML, Madgwick AJ 1996 Slim defines a novel family of LIM-proteins expressed in skeletal muscle. Biochem Biophys Res Commun 225:632-638
14. Genini M, Schwalbe P, Scholl FA, Remppis A, Mattei MG, Schafer BW 1997 Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol 16:433-442
15. Kadrmas JL, Beckerle MC 2004 The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5:920-931
16. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schule R, Buettner R 2006 Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 66:11341-11347
17. Fimia GM, De CD, Sassone-Corsi P 2000 A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol Cell Biol 20:8613-8622
18. Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C, Prieur X, Flajolet M, Prigent S, Buendia MA 2003 Identification of the LIM protein FHL2 as a coactivator of α-catenin. J Biol Chem 278:5188-5194
19. Du X, Hublitz P, Gunther T, Wilhelm D, Englert C, Schule R 2002 The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. Biochim Biophys Acta 1577:93-101
20. Morlon A, Sassone-Corsi P 2003 The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci USA 100:3977-3982
21. Muller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R, Schule R 2002 The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 21:736-748
22. Muller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R, Schule R 2000 FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J 19:359-369
23. Johannessen M, Olsen PA, Johansen B, Seternes OM, Moens U 2003 Activation of the coactivator four-and-a-half-LIM-only protein FHL2 and the c-fos promoter through inhibition of protein phosphatase 2A. Biochem Pharmol 65:1317-1328
24. Heisler LE, Evangelou A, Lew AM, Trachtenberg J, Elsholtz HP, Brown TJ 1997 Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol 126:59-73
25. Endoh M, Zhu W, Hasegawa J, Watanabe H, Kim DK, Aida M, Inukai N, Narita T, Yamada T, Furuya A, Sato H, Yamaguchi Y, Mandal SS, Reinberg D, Wada T, Handa H 2004 Human Spt6 stimulates transcription elongation by RNA polymerase II in vitro. Mol Cell Biol 24:3324-3336
26. Manavathi B, Nair SS, Wang RA, Kumar R, Vadlamudi RK 2005 Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation. Cancer Res 65:5571-5577
27. Khan MM, Hadman M, Wakade C, De Sevilla LM, Dhandapani KM, Mahesh VB, Vadlamudi RK, Brann DW 2005 Cloning, expression, and localization of MNAR/ PELP1 in rodent brain: colocalization in estrogen receptor-α- but not in gonadotropin-releasing hormone-positive neurons. Endocrinology 146:5215-5227
28. Chan KK, Tsui SK, Lee SM, Luk SC, Liew CC, Fung KP, Waye MM, Lee CY 1998 Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 210:345-350
29. Johannessen M, Moller S, Hansen T, Moens U, Van GM 2006 The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 63:268-284
30. Kobayashi S, Shibata H, Yokota K, Suda N, Murai A, Kurihara I, Saito I, Saruta T 2004 FHL2, UBC9, and PIAS1 are novel estrogen receptor α-interacting proteins. Endocr Res 30:617-621
31. Yan J, Zhu J, Zhong H, Lu Q, Huang C, Ye Q 2003 BRCA1 interacts with FHL2 and enhances FHL2 trans-activation function. FEBS Lett 553:183-189
32. Choi YB, Ko JK, Shin J 2004 The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J Biol Chem 279:50930-50941
33. Scholl FA, McLoughlin P, Ehler E, de Giovanni C, Schafer BW 2000 DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol 151:495-506
34. Philippar U, Schratt G, Dieterich C, Muller JM, Galgoczy P, Engel FB, Keating MT, Gertler F, Schule R, Vingron M, Nordheim A 2004 The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol Cell 16:867-880
35. Paul C, Lacroix M, Iankova I, Julien E, Schafer BW, Labalette C, Wei Y, Cam AL, Cam LL, Sardet C 2006 The LIM-only protein FHL2 is a negative regulator of E4F1. Oncogene 25:5475-5484
36. Yang Y, Hou H, Haller EM, Nicosia SV, Bai W 2005 Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J 24:1021-1032
37. Lee LF, Guan J, Qiu Y, Kung HJ 2001 Neuropeptideinduced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 21:8385-8397
38. Joung I, Strominger JL, Shin J 1996 Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc Natl Acad Sci USA 93:5991-5995
39. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M 2004 Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64:7156-7168
40. Jiang T, Guo Z, Dai B, Kang M, Ann DK, Kung HJ, Qiu Y 2004 Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage. J Biol Chem 279:50181-50189
41. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R 2004 p21-Activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 279:1422-1428
42. Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein J, Lee RJ, Segall JE, Westwick JK, Der CJ, Pestell RG 1999 Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-κB- dependent pathway. J Biol Chem 274:25245-25249
43. Schuur ER, Henderson GA, Kmetec LA, Miller, JD, Lamparski HG, Henderson DR 1996 Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem 271:7043-7051